• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生育治疗中生长激素的再利用:一项批判性综述。

The re-growth of growth hormone in fertility treatment: a critical review.

作者信息

Homburg Roy, Singh Anubha, Bhide Priya, Shah Amit, Gudi Anil

机构信息

Homerton Fertility Centre, Homerton University Hospital, London, UK.

出版信息

Hum Fertil (Camb). 2012 Dec;15(4):190-3. doi: 10.3109/14647273.2012.744855. Epub 2012 Nov 28.

DOI:10.3109/14647273.2012.744855
PMID:23190271
Abstract

Several clinical studies have recently been published documenting the possible role of adjuvant growth hormone treatment in in vitro fertilization. These studies have been performed on different groups of patients including poor ovarian responders, patients with polycystic ovary syndrome and with hypogonadotrophic-hypogonadism. The aim of this review is to examine relevant studies in the last 25 years, on the use of growth hormone in assisted conception and trace the train of events that has lead to the resurgence of interest in this subject.

摘要

最近发表了几项临床研究,记录了辅助生长激素治疗在体外受精中的可能作用。这些研究针对不同组别的患者开展,包括卵巢反应不良者、多囊卵巢综合征患者以及低促性腺激素性性腺功能减退患者。本综述的目的是考察过去25年中关于生长激素在辅助受孕中的应用的相关研究,并追溯引发对此主题兴趣再度兴起的一系列事件。

相似文献

1
The re-growth of growth hormone in fertility treatment: a critical review.生育治疗中生长激素的再利用:一项批判性综述。
Hum Fertil (Camb). 2012 Dec;15(4):190-3. doi: 10.3109/14647273.2012.744855. Epub 2012 Nov 28.
2
Modified super-long down-regulation protocol improved the outcome of in vitro fertilization-embryo transfer in infertile patients.改良超长降调节方案改善了不孕患者体外受精-胚胎移植的结局。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2009 Mar;34(3):185-9.
3
The gonadotropin-releasing hormone antagonist protocol--the protocol of choice for the polycystic ovary syndrome patient undergoing controlled ovarian stimulation.促性腺激素释放激素拮抗剂方案——多囊卵巢综合征患者行控制性卵巢刺激的首选方案。
Acta Obstet Gynecol Scand. 2012 Jun;91(6):643-7. doi: 10.1111/j.1600-0412.2012.01399.x. Epub 2012 Apr 30.
4
Extended induction of ovulation by human menopausal gonadotropins and a gonadotropin-releasing hormone analog in high responders for in vitro fertilization and oocyte donation.
J Reprod Med. 1995 Sep;40(9):633-7.
5
Use of a GnRH antagonist in controlled ovarian hyperstimulation for assisted conception in women with polycystic ovary disease: a randomized, prospective, pilot study.GnRH拮抗剂在多囊卵巢疾病女性辅助受孕控制性卵巢刺激中的应用:一项随机、前瞻性、试点研究。
J Reprod Med. 2005 Feb;50(2):84-90.
6
[What is mild stimulation?].
Gynecol Obstet Fertil. 2012 Sep;40(9):467-71. doi: 10.1016/j.gyobfe.2012.07.022. Epub 2012 Aug 21.
7
The use of GnRH analogues in combination with exogenous gonadotropins in infertile women.
Acta Endocrinol Suppl (Copenh). 1988;288:77-84.
8
What is the preferred GnRH analogue for polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in vitro fertilization?对于接受体外受精控制性卵巢刺激的多囊卵巢综合征患者,首选的促性腺激素释放激素类似物是什么?
Fertil Steril. 2009 Apr;91(4 Suppl):1466-8. doi: 10.1016/j.fertnstert.2008.07.1711. Epub 2008 Sep 6.
9
Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.促性腺激素释放激素拮抗剂与二甲双胍用于治疗接受体外受精-胚胎移植的多囊卵巢综合征患者。
Gynecol Endocrinol. 2006 May;22(5):235-8. doi: 10.1080/14767050600761893.
10
Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial.二甲双胍是否会影响多囊卵巢综合征和卵巢储备功能降低患者体外受精治疗中促性腺激素的卵巢反应?一项随机对照试验。
Fertil Steril. 2011 Nov;96(5):1128-33. doi: 10.1016/j.fertnstert.2011.08.020. Epub 2011 Sep 13.

引用本文的文献

1
The Effect of Human Growth Hormone on Endometrial Growth in Controlled Ovarian Hyperstimulation Cycles.人生长激素对控制性卵巢过度刺激周期中子宫内膜生长的影响。
J Pers Med. 2022 Dec 1;12(12):1991. doi: 10.3390/jpm12121991.
2
Preliminary report of intraovarian injections of autologous platelet-rich plasma (PRP) in extremely poor prognosis patients with only oocyte donation as alternative: a prospective cohort study.卵巢内注射自体富血小板血浆(PRP)用于预后极差且仅能选择卵母细胞捐赠患者的初步报告:一项前瞻性队列研究
Hum Reprod Open. 2022 Jun 28;2022(3):hoac027. doi: 10.1093/hropen/hoac027. eCollection 2022.
3
Growth hormone alleviates oxidative stress and improves oocyte quality in Chinese women with polycystic ovary syndrome: a randomized controlled trial.
生长激素缓解多囊卵巢综合征中国女性的氧化应激并改善卵母细胞质量:一项随机对照试验。
Sci Rep. 2020 Oct 30;10(1):18769. doi: 10.1038/s41598-020-75107-4.
4
Mechanism for the Increase in Human Growth Hormone with Administration of a Novel Test Supplement and Results Indicating Improved Physical Fitness and Sleep Efficiency.新型测试补充剂对人体生长激素增加的作用机制及改善身体机能和睡眠效率的结果。
J Med Food. 2021 Jun;24(6):653-659. doi: 10.1089/jmf.2020.0109. Epub 2020 Oct 8.
5
The Evolving Concept of Poor-Prognosis for Women Undertaking IVF and the Notion of Growth Hormone as an Adjuvant; A Single-Center Viewpoint.接受体外受精的女性预后不良的不断演变的概念以及生长激素作为辅助药物的概念;单一中心观点
Front Endocrinol (Lausanne). 2019 Nov 20;10:808. doi: 10.3389/fendo.2019.00808. eCollection 2019.
6
Growth Hormone and Endometrial Receptivity.生长激素与子宫内膜容受性
Front Endocrinol (Lausanne). 2019 Sep 24;10:653. doi: 10.3389/fendo.2019.00653. eCollection 2019.
7
Single-centre retrospective analysis of growth hormone supplementation in IVF patients classified as poor-prognosis.对体外受精(IVF)中被归类为预后不良患者补充生长激素的单中心回顾性分析。
BMJ Open. 2017 Oct 8;7(10):e018107. doi: 10.1136/bmjopen-2017-018107.
8
Growth hormone and reproduction: a review of endocrine and autocrine/paracrine interactions.生长激素与生殖:内分泌和自分泌/旁分泌相互作用的综述。
Int J Endocrinol. 2014;2014:234014. doi: 10.1155/2014/234014. Epub 2014 Dec 15.